1390 A Fc-optimized B7-H3 antibody for induction of NK cell reactivity against acute myeloid leukemia

• Melanie Märklin,
• Ilona Hagelstein,
• Jonas S Heitmann,
• Helmut R Salih,
• Latifa Zekri,
• Martina S Lutz,
• Sylwia A Stefanczyk,
• Stefanie Müller

Affiliations

Melanie Märklin

2Cluster of Excellence iFIT (EXC 2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

Ilona Hagelstein

1Univeristy Hospital Tuebingen, Tuebingen, Germany

Jonas S Heitmann

2Cluster of Excellence iFIT (EXC 2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

Helmut R Salih

1Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

Latifa Zekri

Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany

Martina S Lutz

2Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany

Sylwia A Stefanczyk

2Cluster of Excellence iFIT (EXC 2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

Stefanie Müller

1Univeristy Hospital Tuebingen, Tuebingen, Germany